Literature DB >> 26965581

Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.

Kenneth Friedman1, Alexander S Brodsky1, Shaolei Lu1, Stephanie Wood1, Anthony J Gill2, Kara Lombardo1, Dongfang Yang1, Murray B Resnick1.   

Abstract

Medullary carcinoma of the colon is a unique histologic subtype of microsatellite unstable colorectal carcinoma but little is known regarding its tumor-immunoregulatory microenvironment. The aims of this study were to characterize the immune environment of medullary carcinoma and compare it with other microsatellite unstable and microsatellite stable colorectal carcinomas. An initial gene expression microarray analysis of six cases of medullary carcinoma was used to detect potentially differentially expressed genes. We extended this analysis utilizing genomic data from the Cancer Genome Atlas to compare eight cases of medullary carcinoma with other microsatellite unstable and stable carcinomas. Finally, we evaluated expression of key immune pathway proteins and lymphocyte subsets via immunohistochemistry of a large group of medullary carcinomas (n=105) and compared these findings with three other groups: poorly differentiated, microsatellite unstable well-differentiated and microsatellite stable well-differentiated carcinomas. Microarray and the Cancer Genome Atlas data analysis identified significant upregulation of several immunoregulatory genes induced by IFNγ including IDO-1, WARS (tRNA(trp)), GBP1, GBP4, GBP5, PDCD1 (PD-1), and CD274 (PD-L1) in medullary carcinoma compared with other microsatellite unstable and microsatellite stable tumors. By immunohistochemistry, IDO-1 was expressed in 64% of medullary carcinomas compared with 19% (9/47) of poorly differentiated carcinomas, 14% (3/22) of microsatellite unstable, and 7% (2/30) of the microsatellite stable well-differentiated carcinomas (P<0.0001). tRNA(trp) was overexpressed in 81% (84/104) of medullary carcinomas, 19% (9/47) of poorly differentiated, 32% (7/22) of microsatellite unstable, and 3% (1/30) of microsatellite stable well-differentiated carcinomas (P<0.0001). Medullary carcinoma had higher mean CD8+ and PD-L1+ tumor-infiltrating lymphocytes compared with all other groups (P<0.0001). This study demonstrates overexpression of several immunoregulatory genes in microsatellite unstable colorectal carcinomas and that expression of these genes and proteins is more prevalent in the medullary carcinoma subtype, which may be of use both diagnostically and therapeutically.

Entities:  

Mesh:

Year:  2016        PMID: 26965581     DOI: 10.1038/modpathol.2016.54

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  59 in total

1.  IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells.

Authors:  Sang-Keun Lee; Sam-Hwa Seo; Byoung-Soo Kim; Chang-Deok Kim; Jeung-Hoon Lee; Jung-Soo Kang; Pil Jae Maeng; Jong-Soon Lim
Journal:  J Dermatol Sci       Date:  2005-08-08       Impact factor: 4.563

2.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.

Authors:  Roy S Herbst; Jean-Charles Soria; Marcin Kowanetz; Gregg D Fine; Omid Hamid; Michael S Gordon; Jeffery A Sosman; David F McDermott; John D Powderly; Scott N Gettinger; Holbrook E K Kohrt; Leora Horn; Donald P Lawrence; Sandra Rost; Maya Leabman; Yuanyuan Xiao; Ahmad Mokatrin; Hartmut Koeppen; Priti S Hegde; Ira Mellman; Daniel S Chen; F Stephen Hodi
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

4.  The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer.

Authors:  Arezo Ghanipour; Karin Jirström; Fredrik Pontén; Bengt Glimelius; Lars Påhlman; Helgi Birgisson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

5.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

6.  Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

Authors:  Gerald Brandacher; Alexander Perathoner; Ruth Ladurner; Stefan Schneeberger; Peter Obrist; Christiana Winkler; Ernst R Werner; Gabriele Werner-Felmayer; Helmut G Weiss; Georg Göbel; Raimund Margreiter; Alfred Königsrainer; Dietmar Fuchs; Albert Amberger
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

7.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

Authors:  Mojgan Ahmadzadeh; Laura A Johnson; Bianca Heemskerk; John R Wunderlich; Mark E Dudley; Donald E White; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

8.  Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.

Authors:  David Tougeron; Emilie Fauquembergue; Alexandre Rouquette; Florence Le Pessot; Richard Sesboüé; Michèle Laurent; Pascaline Berthet; Jacques Mauillon; Frédéric Di Fiore; Jean-Christophe Sabourin; Pierre Michel; Mario Tosi; Thierry Frébourg; Jean-Baptiste Latouche
Journal:  Mod Pathol       Date:  2009-06-05       Impact factor: 7.842

Review 9.  Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.

Authors:  Michael Platten; Nikolaus von Knebel Doeberitz; Iris Oezen; Wolfgang Wick; Katharina Ochs
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  19 in total

1.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.

Authors:  Jinru Shia; Nikolaus Schultz; Deborah Kuk; Efsevia Vakiani; Sumit Middha; Neil H Segal; Jaclyn F Hechtman; Michael F Berger; Zsofia K Stadler; Martin R Weiser; Jedd D Wolchok; C Richard Boland; Mithat Gönen; David S Klimstra
Journal:  Mod Pathol       Date:  2016-12-16       Impact factor: 7.842

3.  Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.

Authors:  Gabriel Acosta-Gonzalez; Madhu Ouseph; Kara Lombardo; Shaolei Lu; Jonathan Glickman; Murray B Resnick
Journal:  Hum Pathol       Date:  2018-08-31       Impact factor: 3.466

4.  Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium.

Authors:  Brian C Willis; Emily A Sloan; Kristen A Atkins; Mark H Stoler; Anne M Mills
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

5.  Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications.

Authors:  Lik Hang Lee; Rhonda K Yantiss; Eran Sadot; Bing Ren; Marcela Santos Calvacanti; Jaclyn F Hechtman; Sinisa Ivelja; Be Huynh; Yue Xue; Tatiana Shitilbans; Hamza Guend; Zsofia K Stadler; Martin R Weiser; Efsevia Vakiani; Mithat Gönen; David S Klimstra; Jinru Shia
Journal:  Hum Pathol       Date:  2016-12-26       Impact factor: 3.466

6.  Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.

Authors:  Yan Qu; Shuqing Zhang; Yan Zhang; Xien Feng; Fengjuan Wang
Journal:  Virchows Arch       Date:  2020-11-12       Impact factor: 4.064

7.  Expression of Indoleamine 2, 3-dioxygenase 1 (IDO1) and Tryptophanyl-tRNA Synthetase (WARS) in Gastric Cancer Molecular Subtypes.

Authors:  Shaolei Lu; Li Juan Wang; Kara Lombardo; Yoonjin Kwak; Woo Ho Kim; Murray B Resnick
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020 May/Jun

8.  PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.

Authors:  Jacqueline Fontugne; Jérémy Augustin; Anaïs Pujals; Philippe Compagnon; Benoit Rousseau; Alain Luciani; Christophe Tournigand; Daniel Cherqui; Daniel Azoulay; Jean-Michel Pawlotsky; Julien Calderaro
Journal:  Oncotarget       Date:  2017-04-11

9.  PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments.

Authors:  Anna Maria Valentini; Federica Di Pinto; Filomena Cariola; Vito Guerra; Gianluigi Giannelli; Maria Lucia Caruso; Michele Pirrelli
Journal:  Oncotarget       Date:  2018-01-12

10.  Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway.

Authors:  Stephanie M Wood; Anthony J Gill; Alexander S Brodsky; Shaolei Lu; Kenneth Friedman; Galina Karashchuk; Kara Lombardo; Dongfang Yang; Murray B Resnick
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.